Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyBiologicalProcess	organelle assembly	IFT140 HAUS6 MIS12 BRCA1 EIF2S1 SYNE1 CNTRL DLGAP5 DIAPH3 NEB MAP10 DNMBP SMCR8 SPAG6 CCDC136	2.01e-05	1138	78	15	GO:0070925
GeneOntologyCellularComponent	BRCA1-BARD1 complex	BRCA1 BARD1	1.37e-05	2	78	2	GO:0031436
GeneOntologyCellularComponent	BRCA1-B complex	BRCA1 BARD1	8.21e-05	4	78	2	GO:0070532
GeneOntologyCellularComponent	ATP-binding cassette (ABC) transporter complex	ABCA2 ABCG5	2.04e-04	6	78	2	GO:0043190
GeneOntologyCellularComponent	BRCA1-C complex	BRCA1 BARD1	2.04e-04	6	78	2	GO:0070533
GeneOntologyCellularComponent	BRCA1-A complex	BRCA1 BARD1	3.79e-04	8	78	2	GO:0070531
Domain	-	GTF2IRD2B GTF2IRD2	9.75e-05	4	76	2	3.90.1460.10
Domain	GTF2I	GTF2IRD2B GTF2IRD2	9.75e-05	4	76	2	PS51139
Domain	GTF2I	GTF2IRD2B GTF2IRD2	9.75e-05	4	76	2	PF02946
Domain	GTF2I	GTF2IRD2B GTF2IRD2	9.75e-05	4	76	2	IPR004212
Domain	AAA+_ATPase	ABCA2 ATAD5 RFC5 FIGNL1 ABCG5	3.02e-04	144	76	5	IPR003593
Domain	AAA	ABCA2 ATAD5 RFC5 FIGNL1 ABCG5	3.02e-04	144	76	5	SM00382
Domain	AAA	ATAD5 RFC5 FIGNL1	1.24e-03	52	76	3	PF00004
Domain	ATPase_AAA_core	ATAD5 RFC5 FIGNL1	1.38e-03	54	76	3	IPR003959
Domain	BRCT	BRCA1 BARD1	2.67e-03	19	76	2	PF00533
Domain	FCH	SRGAP3 FER	3.58e-03	22	76	2	PF00611
Domain	BRCT	BRCA1 BARD1	3.58e-03	22	76	2	SM00292
Domain	FCH	SRGAP3 FER	3.58e-03	22	76	2	SM00055
Domain	FCH_dom	SRGAP3 FER	3.91e-03	23	76	2	IPR001060
Domain	-	BRCA1 BARD1	3.91e-03	23	76	2	3.40.50.10190
Domain	TPR_REGION	IFT140 NAA25 TTC4 CLUH	4.60e-03	165	76	4	PS50293
Domain	TPR	IFT140 NAA25 TTC4 CLUH	4.60e-03	165	76	4	PS50005
Domain	F_BAR	SRGAP3 FER	4.61e-03	25	76	2	IPR031160
Domain	F_BAR	SRGAP3 FER	4.61e-03	25	76	2	PS51741
Domain	BRCT	BRCA1 BARD1	4.99e-03	26	76	2	PS50172
Domain	BRCT_dom	BRCA1 BARD1	5.77e-03	28	76	2	IPR001357
Domain	Spectrin_repeat	SYNE1 MCF2	6.18e-03	29	76	2	IPR002017
Domain	Spectrin/alpha-actinin	SYNE1 MCF2	7.49e-03	32	76	2	IPR018159
Domain	SPEC	SYNE1 MCF2	7.49e-03	32	76	2	SM00150
Pathway	REACTOME_HDR_THROUGH_HOMOLOGOUS_RECOMBINATION_HRR	BRCA1 BARD1 RFC5 FIGNL1	7.49e-05	59	54	4	MM15283
Pathway	REACTOME_HDR_THROUGH_HOMOLOGOUS_RECOMBINATION_HRR	BRCA1 BARD1 RFC5 FIGNL1	1.46e-04	70	54	4	M27570
Pathway	REACTOME_METALLOPROTEASE_DUBS	BRCA1 BARD1 NLRP3	1.81e-04	29	54	3	MM15291
Pathway	REACTOME_CELL_CYCLE	HAUS6 MIS12 BRCA1 SYNE1 CNTRL HJURP SYCP1 BARD1 RFC5 FIGNL1	2.62e-04	694	54	10	M543
Pathway	KEGG_MEDICUS_REFERENCE_HOMOLOGOUS_RECOMBINATION	BRCA1 BARD1 RFC5	2.67e-04	33	54	3	M47842
Pathway	REACTOME_RESOLUTION_OF_D_LOOP_STRUCTURES	BRCA1 BARD1 FIGNL1	3.19e-04	35	54	3	MM15293
Pathway	REACTOME_REPRODUCTION	BRCA1 SYNE1 SYCP1 ZP2 FIGNL1	3.37e-04	158	54	5	M26956
Pathway	REACTOME_HDR_THROUGH_SINGLE_STRAND_ANNEALING_SSA	BRCA1 BARD1 RFC5	3.47e-04	36	54	3	MM15281
Pathway	REACTOME_RESOLUTION_OF_D_LOOP_STRUCTURES	BRCA1 BARD1 FIGNL1	3.76e-04	37	54	3	M27583
Pathway	REACTOME_METALLOPROTEASE_DUBS	BRCA1 BARD1 NLRP3	3.76e-04	37	54	3	M27580
Pathway	REACTOME_HDR_THROUGH_SINGLE_STRAND_ANNEALING_SSA	BRCA1 BARD1 RFC5	3.76e-04	37	54	3	M27568
Pathway	BIOCARTA_BARD1_PATHWAY	BRCA1 BARD1	3.97e-04	8	54	2	M22050
Pathway	REACTOME_HOMOLOGOUS_DNA_PAIRING_AND_STRAND_EXCHANGE	BRCA1 BARD1 RFC5	5.88e-04	43	54	3	M27588
Pathway	REACTOME_DISEASES_OF_DNA_REPAIR	BRCA1 BARD1 RFC5	9.72e-04	51	54	3	M29854
Pathway	REACTOME_HOMOLOGY_DIRECTED_REPAIR	BRCA1 BARD1 RFC5 FIGNL1	1.00e-03	116	54	4	MM15294
Pathway	REACTOME_MEIOSIS	BRCA1 SYNE1 SYCP1 FIGNL1	1.14e-03	120	54	4	M529
Pubmed	Regulation of BRCA1 stability through the tandem UBX domains of isoleucyl-tRNA synthetase 1.	EPRS1 BRCA1 BARD1	6.03e-07	8	78	3	36347866
Pubmed	Functional Analysis of BARD1 Missense Variants in Homology-Directed Repair of DNA Double Strand Breaks.	BRCA1 BARD1	4.97e-06	2	78	2	26350354
Pubmed	BARD1 regulates BRCA1 apoptotic function by a mechanism involving nuclear retention.	BRCA1 BARD1	4.97e-06	2	78	2	15265711
Pubmed	Identification of a RING protein that can interact in vivo with the BRCA1 gene product.	BRCA1 BARD1	4.97e-06	2	78	2	8944023
Pubmed	Two redundant ubiquitin-dependent pathways of BRCA1 localization to DNA damage sites.	BRCA1 BARD1	4.97e-06	2	78	2	34726323
Pubmed	Molecular Analysis of BRCA1 in Human Breast Cancer Cells Under Oxidative Stress.	BRCA1 BARD1	4.97e-06	2	78	2	28262780
Pubmed	BRCA1 DNA-binding activity is stimulated by BARD1.	BRCA1 BARD1	4.97e-06	2	78	2	16489000
Pubmed	BRCA1 : BARD1 induces the formation of conjugated ubiquitin structures, dependent on K6 of ubiquitin, in cells during DNA replication and repair.	BRCA1 BARD1	4.97e-06	2	78	2	14976165
Pubmed	Identification of residues required for the interaction of BARD1 with BRCA1.	BRCA1 BARD1	4.97e-06	2	78	2	11773071
Pubmed	Depletion of eIF2·GTP·Met-tRNAi translation initiation complex up-regulates BRCA1 expression in vitro and in vivo.	BRCA1 EIF2S1	4.97e-06	2	78	2	25762631
Pubmed	BARD1 participates with BRCA1 in homology-directed repair of chromosome breaks.	BRCA1 BARD1	4.97e-06	2	78	2	14560035
Pubmed	The BRCA Tumor Suppressor Network in Chromosome Damage Repair by Homologous Recombination.	BRCA1 BARD1	4.97e-06	2	78	2	30917004
Pubmed	Cell cycle-dependent colocalization of BARD1 and BRCA1 proteins in discrete nuclear domains.	BRCA1 BARD1	4.97e-06	2	78	2	9342365
Pubmed	Nuclear-cytoplasmic shuttling of BARD1 contributes to its proapoptotic activity and is regulated by dimerization with BRCA1.	BRCA1 BARD1	4.97e-06	2	78	2	14647430
Pubmed	Computational structural assessment of BReast CAncer type 1 susceptibility protein (BRCA1) and BRCA1-Associated Ring Domain protein 1 (BARD1) mutations on the protein-protein interface.	BRCA1 BARD1	4.97e-06	2	78	2	35534113
Pubmed	Re-engineering a split-GFP reassembly screen to examine RING-domain interactions between BARD1 and BRCA1 mutants observed in cancer patients.	BRCA1 BARD1	4.97e-06	2	78	2	18493658
Pubmed	Structural insight into BRCA1-BARD1 complex recruitment to damaged chromatin.	BRCA1 BARD1	4.97e-06	2	78	2	34102105
Pubmed	Quantitative proteomic identification of the BRCA1 ubiquitination substrates.	BRCA1 BARD1	4.97e-06	2	78	2	21950761
Pubmed	The basal-like mammary carcinomas induced by Brca1 or Bard1 inactivation implicate the BRCA1/BARD1 heterodimer in tumor suppression.	BRCA1 BARD1	4.97e-06	2	78	2	18443292
Pubmed	Mapping the functional domains of BRCA1. Interaction of the ring finger domains of BRCA1 and BARD1.	BRCA1 BARD1	4.97e-06	2	78	2	10026184
Pubmed	The BRCT Domains of the BRCA1 and BARD1 Tumor Suppressors Differentially Regulate Homology-Directed Repair and Stalled Fork Protection.	BRCA1 BARD1	4.97e-06	2	78	2	30244837
Pubmed	Tamoxifen-resistant breast cancer cells are resistant to DNA-damaging chemotherapy because of upregulated BARD1 and BRCA1.	BRCA1 BARD1	4.97e-06	2	78	2	29686231
Pubmed	Structure of a BRCA1-BARD1 heterodimeric RING-RING complex.	BRCA1 BARD1	4.97e-06	2	78	2	11573085
Pubmed	Differential modulation of BRCA1 and BARD1 nuclear localisation and foci assembly by DNA damage.	BRCA1 BARD1	4.97e-06	2	78	2	19796682
Pubmed	The BRCA1/BARD1 ubiquitin ligase and its substrates.	BRCA1 BARD1	4.97e-06	2	78	2	34591954
Pubmed	BRCA1 RING domain cancer-predisposing mutations. Structural consequences and effects on protein-protein interactions.	BRCA1 BARD1	4.97e-06	2	78	2	11526114
Pubmed	The BRCA1 variant p.Ser36Tyr abrogates BRCA1 protein function and potentially confers a moderate risk of breast cancer.	BRCA1 BARD1	4.97e-06	2	78	2	24695549
Pubmed	BRCA1 tumour suppression occurs via heterochromatin-mediated silencing.	BRCA1 BARD1	4.97e-06	2	78	2	21901007
Pubmed	Hyperphosphorylation of the BARD1 tumor suppressor in mitotic cells.	BRCA1 BARD1	4.97e-06	2	78	2	15855157
Pubmed	BARD1 induces BRCA1 intranuclear foci formation by increasing RING-dependent BRCA1 nuclear import and inhibiting BRCA1 nuclear export.	BRCA1 BARD1	4.97e-06	2	78	2	11925436
Pubmed	Function of BRCA1 in the DNA damage response is mediated by ADP-ribosylation.	BRCA1 BARD1	4.97e-06	2	78	2	23680151
Pubmed	Genetic analysis of BRCA1 function in a defined tumor cell line.	BRCA1 BARD1	4.97e-06	2	78	2	10635334
Pubmed	DNA damage-induced BARD1 phosphorylation is critical for the inhibition of messenger RNA processing by BRCA1/BARD1 complex.	BRCA1 BARD1	4.97e-06	2	78	2	16651405
Pubmed	Ubiquitination and proteasome-mediated degradation of BRCA1 and BARD1 during steroidogenesis in human ovarian granulosa cells.	BRCA1 BARD1	4.97e-06	2	78	2	17185394
Pubmed	Massively Parallel Functional Analysis of BRCA1 RING Domain Variants.	BRCA1 BARD1	4.97e-06	2	78	2	25823446
Pubmed	Comparison of TFII-I gene family members deleted in Williams-Beuren syndrome.	GTF2IRD2B GTF2IRD2	4.97e-06	2	78	2	15388857
Pubmed	BRCA1-BARD1 combines multiple chromatin recognition modules to bridge nascent nucleosomes.	BRCA1 BARD1	4.97e-06	2	78	2	37823591
Pubmed	Mechanism of BRCA1-BARD1 function in DNA end resection and DNA protection.	BRCA1 BARD1	4.97e-06	2	78	2	39261728
Pubmed	Promotion of DNA end resection by BRCA1-BARD1 in homologous recombination.	BRCA1 BARD1	4.97e-06	2	78	2	39261729
Pubmed	Protein-protein interactions between large proteins: two-hybrid screening using a functionally classified library composed of long cDNAs.	IFT140 VPS13D ABCA2 CLUH UNC13A	1.15e-05	130	78	5	12421765
Pubmed	PI 3 kinase related kinases-independent proteolysis of BRCA1 regulates Rad51 recruitment during genotoxic stress in human cells.	BRCA1 BARD1	1.49e-05	3	78	2	21103343
Pubmed	Ubiquitination and downregulation of BRCA1 by ubiquitin-conjugating enzyme E2T overexpression in human breast cancer cells.	BRCA1 BARD1	1.49e-05	3	78	2	19887602
Pubmed	Negative feedback loop of BRCA1-BARD1 ubiquitin ligase on estrogen receptor alpha stability and activity antagonized by cancer-associated isoform of BARD1.	BRCA1 BARD1	1.49e-05	3	78	2	20060929
Pubmed	BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function.	BRCA1 BARD1	1.49e-05	3	78	2	11301010
Pubmed	Liver X receptor ligands suppress ubiquitination and degradation of LXRalpha by displacing BARD1/BRCA1.	BRCA1 BARD1	1.49e-05	3	78	2	19164445
Pubmed	RNAi Screening Uncovers a Synthetic Sick Interaction between CtIP and the BARD1 Tumor Suppressor.	BRCA1 BARD1	1.49e-05	3	78	2	35203293
Pubmed	Frequent incidence of BARD1-truncating mutations in germline DNA from triple-negative breast cancer patients.	BRCA1 BARD1	1.49e-05	3	78	2	26010302
Pubmed	Mass spectrometric and mutational analyses reveal Lys-6-linked polyubiquitin chains catalyzed by BRCA1-BARD1 ubiquitin ligase.	BRCA1 BARD1	1.49e-05	3	78	2	14638690
Pubmed	BRCA1 binds c-Myc and inhibits its transcriptional and transforming activity in cells.	BRCA1 BARD1	1.49e-05	3	78	2	9788437
Pubmed	RNF19A-mediated ubiquitination of BARD1 prevents BRCA1/BARD1-dependent homologous recombination.	BRCA1 BARD1	1.49e-05	3	78	2	34789768
Pubmed	Negative regulation of BRCA1 by transforming acidic coiled-coil protein 3 (TACC3).	BRCA1 BARD1	1.49e-05	3	78	2	29355525
Pubmed	p53-dependent BRCA1 nuclear export controls cellular susceptibility to DNA damage.	BRCA1 BARD1	1.49e-05	3	78	2	21742769
Pubmed	SIRT2 promotes BRCA1-BARD1 heterodimerization through deacetylation.	BRCA1 BARD1	1.49e-05	3	78	2	33789098
Pubmed	The antitumorigenic roles of BRCA1-BARD1 in DNA repair and replication.	BRCA1 BARD1	1.49e-05	3	78	2	32094664
Pubmed	Cellular responses of BRCA1-defective and triple-negative breast cancer cells and in vitro BRCA1 interactions induced by metallo-intercalator ruthenium(II) complexes containing chloro-substituted phenylazopyridine.	BRCA1 BARD1	1.49e-05	3	78	2	24507701
Pubmed	Rapid recruitment of BRCA1 to DNA double-strand breaks is dependent on its association with Ku80.	BRCA1 BARD1	1.49e-05	3	78	2	18936166
Pubmed	BLM and BRCA1-BARD1 coordinate complementary mechanisms of joint DNA molecule resolution.	BRCA1 BARD1	1.49e-05	3	78	2	38266639
Pubmed	Conservation of function and primary structure in the BRCA1-associated RING domain (BARD1) protein.	BRCA1 BARD1	1.49e-05	3	78	2	9798686
Pubmed	Mediator of DNA damage checkpoint protein 1 regulates BRCA1 localization and phosphorylation in DNA damage checkpoint control.	BRCA1 BARD1	1.49e-05	3	78	2	12611903
Pubmed	Polymorphisms in HPV E6/E7 protein interacted genes and risk of cervical cancer in Chinese women: a case-control analysis.	BRCA1 BARD1	1.49e-05	3	78	2	19482343
Pubmed	Enhancement of BRCA1 E3 ubiquitin ligase activity through direct interaction with the BARD1 protein.	BRCA1 BARD1	1.49e-05	3	78	2	12431996
Pubmed	BRCA1/BARD1 inhibition of mRNA 3' processing involves targeted degradation of RNA polymerase II.	BRCA1 BARD1	1.49e-05	3	78	2	15905410
Pubmed	Collaboration of Werner syndrome protein and BRCA1 in cellular responses to DNA interstrand cross-links.	BRCA1 BARD1	1.49e-05	3	78	2	16714450
Pubmed	BRCA1-associated protein 1 interferes with BRCA1/BARD1 RING heterodimer activity.	BRCA1 BARD1	1.49e-05	3	78	2	19117993
Pubmed	Genetic analysis of BRCA1 ubiquitin ligase activity and its relationship to breast cancer susceptibility.	BRCA1 BARD1	1.49e-05	3	78	2	16403807
Pubmed	Nucleophosmin/B23 is a candidate substrate for the BRCA1-BARD1 ubiquitin ligase.	BRCA1 BARD1	1.49e-05	3	78	2	15184379
Pubmed	BRCA1 recruitment to damaged DNA sites is dependent on CDK9.	BRCA1 BARD1	1.49e-05	3	78	2	28278048
Pubmed	Isolation and characterisation of GTF2IRD2, a novel fusion gene and member of the TFII-I family of transcription factors, deleted in Williams-Beuren syndrome.	GTF2IRD2B GTF2IRD2	1.49e-05	3	78	2	15100712
Pubmed	A novel breast cancer-associated BRIP1 (FANCJ/BACH1) germ-line mutation impairs protein stability and function.	BRCA1 BARD1	1.49e-05	3	78	2	18628483
Pubmed	Human BRCA1-BARD1 ubiquitin ligase activity counteracts chromatin barriers to DNA resection.	BRCA1 BARD1	1.49e-05	3	78	2	27239795
Pubmed	Regulation of BRCA1, BRCA2 and BARD1 intracellular trafficking.	BRCA1 BARD1	1.49e-05	3	78	2	16108063
Pubmed	RING domain-deficient BRCA1 promotes PARP inhibitor and platinum resistance.	BRCA1 BARD1	1.49e-05	3	78	2	27454289
Pubmed	Cancer predisposing missense and protein truncating BARD1 mutations in non-BRCA1 or BRCA2 breast cancer families.	BRCA1 BARD1	1.49e-05	3	78	2	20077502
Pubmed	The BRCA1 RING and BRCT domains cooperate in targeting BRCA1 to ionizing radiation-induced nuclear foci.	BRCA1 BARD1	1.49e-05	3	78	2	15569676
Pubmed	Evaluation of BRCA1-related molecular features and microRNAs as prognostic factors for triple negative breast cancers.	BRCA1 BARD1	1.49e-05	3	78	2	26490435
Pubmed	Disrupted in Schizophrenia 1 Interactome: evidence for the close connectivity of risk genes and a potential synaptic basis for schizophrenia.	SRGAP3 SYNE1 EXOC1 ZNF91 CCDC136	2.36e-05	151	78	5	17043677
Pubmed	Loss of Bard1, the heterodimeric partner of the Brca1 tumor suppressor, results in early embryonic lethality and chromosomal instability.	BRCA1 BARD1	2.97e-05	4	78	2	12832489
Pubmed	N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.	NAA25 FAM111B	2.97e-05	4	78	2	22814378
Pubmed	Evolution of general transcription factors.	GTF2IRD2B GTF2IRD2	2.97e-05	4	78	2	23229069
Pubmed	GTF2IRD2 from the Williams-Beuren critical region encodes a mobile-element-derived fusion protein that antagonizes the action of its related family members.	GTF2IRD2B GTF2IRD2	2.97e-05	4	78	2	22899722
Pubmed	BARD1 is necessary for ubiquitylation of nucleosomal histone H2A and for transcriptional regulation of estrogen metabolism genes.	BRCA1 BARD1	2.97e-05	4	78	2	29367421
Pubmed	The BARD1-CstF-50 interaction links mRNA 3' end formation to DNA damage and tumor suppression.	BRCA1 BARD1	2.97e-05	4	78	2	11257228
Pubmed	BRCA1-Interacting Protein OLA1 Requires Interaction with BARD1 to Regulate Centrosome Number.	BRCA1 BARD1	2.97e-05	4	78	2	29858377
Pubmed	BRCA1/BARD1 ubiquitinate phosphorylated RNA polymerase II.	BRCA1 BARD1	2.97e-05	4	78	2	15886201
Pubmed	Germline mutations in the DNA damage response genes BRCA1, BRCA2, BARD1 and TP53 in patients with therapy related myeloid neoplasms.	BRCA1 BARD1	2.97e-05	4	78	2	22652532
Pubmed	L ARP7 Is a BRCA1 Ubiquitinase Substrate and Regulates Genome Stability and Tumorigenesis.	BRCA1 BARD1	2.97e-05	4	78	2	32726637
Pubmed	The BRCA1/BARD1-interacting protein OLA1 functions in centrosome regulation.	BRCA1 BARD1	2.97e-05	4	78	2	24289923
Pubmed	FOXK2 transcription factor suppresses ERα-positive breast cancer cell growth through down-regulating the stability of ERα via mechanism involving BRCA1/BARD1.	BRCA1 BARD1	2.97e-05	4	78	2	25740706
Pubmed	TFII-I gene family during tooth development: candidate genes for tooth anomalies in Williams syndrome.	GTF2IRD2B GTF2IRD2	2.97e-05	4	78	2	17823943
Pubmed	Identification of Xin-repeat proteins as novel ligands of the SH3 domains of nebulin and nebulette and analysis of their interaction during myofibril formation and remodeling.	XIRP2 NEB	2.97e-05	4	78	2	23985323
Pubmed	The BRCA1/BARD1 heterodimer assembles polyubiquitin chains through an unconventional linkage involving lysine residue K6 of ubiquitin.	BRCA1 BARD1	2.97e-05	4	78	2	12890688
Pubmed	BRCA1-BARD1 regulates transcription through modulating topoisomerase IIβ.	BRCA1 BARD1	2.97e-05	4	78	2	34610268
Pubmed	Expression of human BRCA1Δ17-19 alternative splicing variant with a truncated BRCT domain in MCF-7 cells results in impaired assembly of DNA repair complexes and aberrant DNA damage response.	BRCA1 BARD1	2.97e-05	4	78	2	23416467
Pubmed	Impact of RING and BRCT domain mutations on BRCA1 protein stability, localization and recruitment to DNA damage.	BRCA1 BARD1	2.97e-05	4	78	2	20681793
Pubmed	The Histone Variant MacroH2A1 Is a BRCA1 Ubiquitin Ligase Substrate.	BRCA1 BARD1	2.97e-05	4	78	2	28564596
Pubmed	Haploinsufficiency of Gtf2i, a gene deleted in Williams Syndrome, leads to increases in social interactions.	GTF2IRD2B GTF2IRD2	2.97e-05	4	78	2	21328569
Pubmed	Identification and characterization of NIF3L1 BP1, a novel cytoplasmic interaction partner of the NIF3L1 protein.	BRCA1 BARD1	2.97e-05	4	78	2	12951069
Pubmed	BRCA1/BARD1 E3 ubiquitin ligase can modify histones H2A and H2B in the nucleosome particle.	BRCA1 BARD1	2.97e-05	4	78	2	19916563
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	HAUS6 BRCA1 ATAD5 RBMS1 FER EXOC1 DIAPH3 DNMBP CLUH	3.54e-05	724	78	9	36232890
Pubmed	Tuning BRCA1 and BARD1 activity to investigate RING ubiquitin ligase mechanisms.	BRCA1 BARD1	4.94e-05	5	78	2	27977889
GeneFamily	Ankyrin repeat domain containing\|BRCA1 B complex	BRCA1 BARD1	4.48e-05	4	50	2	1335
GeneFamily	AAA ATPases	ATAD5 RFC5 FIGNL1	4.23e-04	53	50	3	413
GeneFamily	Rho GTPase activating proteins\|F-BAR domain containing	SRGAP3 FER	1.83e-03	23	50	2	1288
Coexpression	GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_2H_UP	BRCA1 ATAD5 SRGAP3 BARD1 NEB FIGNL1 FRMD4B	1.25e-06	183	78	7	M2993
Coexpression	HE_LIM_SUN_FETAL_LUNG_C5_PRO_B_CELL	BRCA1 ATAD5 HMGXB4 DLGAP5 HJURP BARD1 RASD1 DIAPH3 FIGNL1 FAM111B	1.54e-06	478	78	10	M45785
Coexpression	LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_LARGE_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP	HAUS6 BRCA1 ATAD5 DLGAP5 HJURP BARD1 DIAPH3 RFC5 FIGNL1	3.08e-06	402	78	9	MM454
Coexpression	HE_LIM_SUN_FETAL_LUNG_C2_CYCLING_DC_CELL	PMS1 HAUS6 MIS12 BRCA1 ATAD5 HMGXB4 DLGAP5 CYP51A1 HJURP BARD1 DIAPH3 RFC5 TTC4 FIGNL1 FILIP1L FAM111B	3.69e-06	1423	78	16	M45722
Coexpression	HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_T_CELL	PMS1 HAUS6 BRCA1 ATAD5 CNTRL HMGXB4 DLGAP5 HJURP BARD1 DIAPH3 RFC5 FIGNL1 FAM111B	3.76e-06	939	78	13	M45768
Coexpression	FISCHER_DREAM_TARGETS	HAUS6 MIS12 BRCA1 ATAD5 HMGXB4 DLGAP5 CYP51A1 HJURP BARD1 DIAPH3 RFC5 FIGNL1 FAM111B	5.29e-06	969	78	13	M149
Coexpression	HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_NK_CELL	HAUS6 MIS12 BRCA1 ATAD5 HMGXB4 DLGAP5 HJURP BARD1 DIAPH3 RFC5 FAM111B	6.44e-06	694	78	11	M45767
Coexpression	FAN_EMBRYONIC_CTX_MICROGLIA_1	ATAD5 CNTRL DLGAP5 HJURP BARD1 DIAPH3	7.02e-06	155	78	6	M39041
Coexpression	HE_LIM_SUN_FETAL_LUNG_C5_LARGE_PRE_B_CELL	PMS1 EPRS1 HAUS6 MIS12 BRCA1 ATAD5 EIF2S1 HMGXB4 DLGAP5 HJURP BARD1 DIAPH3 RFC5 FIGNL1 FAM111B	1.01e-05	1363	78	15	M45782
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	PMS1 AFAP1 WASHC4 BRCA1 RBMS1 HMGXB4 BARD1 DNMBP FILIP1L	1.01e-05	466	78	9	M13522
Coexpression	GSE40274_CTRL_VS_FOXP3_AND_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	HAUS6 MIS12 EIF2S1 CYP51A1 FIGNL1 FRMD4B	1.04e-05	166	78	6	M9114
Coexpression	DODD_NASOPHARYNGEAL_CARCINOMA_UP	PMS1 COL5A1 EPRS1 HAUS6 NAA25 AFAP1 BRCA1 HMGXB4 DLGAP5 HJURP DIAPH3 RFC5 FAS FIGNL1 CLCC1	1.47e-05	1407	78	15	M14427
Coexpression	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP	PMS1 EPRS1 HAUS6 BRCA1 TMEM45A EIF2S1 DLGAP5 CYP51A1 DIAPH3 FIGNL1	2.09e-05	644	78	10	M10501
Coexpression	HE_LIM_SUN_FETAL_LUNG_C2_PROMONOCYTE_LIKE_CELL	BRCA1 ATAD5 DLGAP5 HJURP BARD1 DIAPH3 RFC5	2.55e-05	290	78	7	M45736
Coexpression	GSE7460_CTRL_VS_TGFB_TREATED_ACT_TREG_UP	HAUS6 ATAD5 EIF2S1 CYP51A1 FIGNL1 CLCC1	2.98e-05	200	78	6	M5680
Coexpression	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP	PMS1 COL5A1 HAUS6 DLGAP5 DIAPH3 FAS FIGNL1	3.52e-05	305	78	7	M19875
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	PMS1 TAOK3 AFAP1 WASHC4 BRCA1 RBMS1 HMGXB4 DLGAP5 BARD1 DNMBP FILIP1L	4.47e-05	856	78	11	M4500
Coexpression	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	BRCA1 ATAD5 DLGAP5 BARD1 RFC5 FIGNL1 FAM111B	5.05e-05	323	78	7	M2156
Coexpression	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP	PMS1 EPRS1 HAUS6 WASHC4 EIF2S1 RBMS1 DIAPH3 ZNF91 FAS FIGNL1	5.43e-05	721	78	10	M10237
Coexpression	HE_LIM_SUN_FETAL_LUNG_C7_SCHWANN_PRECURSOR_CELL	ATAD5 DLGAP5 HJURP BARD1 DIAPH3 FILIP1L	6.80e-05	232	78	6	M45800
Coexpression	MARKEY_RB1_ACUTE_LOF_UP	BRCA1 DLGAP5 HJURP RFC5 FAS FIGNL1	7.65e-05	237	78	6	M15606
Coexpression	ZHONG_PFC_C1_OPC	HAUS6 BRCA1 DLGAP5 HJURP BARD1 DIAPH3	7.83e-05	238	78	6	M39096
Coexpression	MARKEY_RB1_ACUTE_LOF_UP	BRCA1 DLGAP5 HJURP RFC5 FAS FIGNL1	8.20e-05	240	78	6	MM976
Coexpression	HAMAI_APOPTOSIS_VIA_TRAIL_UP	EPRS1 HAUS6 TAOK3 BRCA1 DLGAP5 FER EXOC1 DIAPH3 ZNF354B	1.43e-04	656	78	9	M18979
Coexpression	ZHONG_PFC_C3_UNKNOWN_INP	NEUROD4 DLGAP5 HJURP	1.98e-04	38	78	3	M39083
Coexpression	GUO_TARGETS_OF_IRS1_AND_IRS2	TAOK3 RBMS1 CYP51A1 ABCG5	2.04e-04	97	78	4	MM1318
Coexpression	GUO_TARGETS_OF_IRS1_AND_IRS2	TAOK3 RBMS1 CYP51A1 ABCG5	2.04e-04	97	78	4	M2434
Coexpression	KONG_E2F3_TARGETS	BRCA1 DLGAP5 HJURP FIGNL1	2.04e-04	97	78	4	MM1105
Coexpression	GSE6259_CD4_TCELL_VS_CD8_TCELL_DN	TAOK3 PEAK1 SMCR8 FRMD4B CLCC1	2.25e-04	184	78	5	M6739
Coexpression	KONG_E2F3_TARGETS	BRCA1 DLGAP5 HJURP FIGNL1	2.29e-04	100	78	4	M1157
Coexpression	BURTON_ADIPOGENESIS_3	BRCA1 DLGAP5 RFC5 FIGNL1	2.38e-04	101	78	4	M1577
Coexpression	BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_DEL_NS1_INFECTION_DN	BRCA1 ATAD5 HJURP DIAPH3 FAM111B	2.43e-04	187	78	5	M34027
Coexpression	BURTON_ADIPOGENESIS_3	BRCA1 DLGAP5 RFC5 FIGNL1	2.66e-04	104	78	4	MM1180
Coexpression	MARSON_BOUND_BY_E2F4_UNSTIMULATED	HAUS6 MIS12 DLGAP5 HJURP BARD1 CDNF DIAPH3 SMCR8 FIGNL1	2.68e-04	714	78	9	M1744
Coexpression	HE_LIM_SUN_FETAL_LUNG_C7_PROLIFERATING_SCHWANN_CELL	COL5A1 VPS13D BRCA1 TMEM45A DLGAP5 HJURP DIAPH3 PEAK1 KDM5D FRMD4B FAM111B	2.79e-04	1054	78	11	M45798
Coexpression	GSE25088_WT_VS_STAT6_KO_MACROPHAGE_ROSIGLITAZONE_STIM_UP	SORT1 EPRS1 CEP85L FRMD4B FILIP1L	2.87e-04	194	78	5	M8019
Coexpression	GSE18893_TCONV_VS_TREG_2H_TNF_STIM_DN	CCDC186 ZNF91 DNMBP JMY NLRP3	2.87e-04	194	78	5	M7306
Coexpression	GSE21546_WT_VS_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_DN	BRCA1 HMGXB4 FIGNL1 CCDC136 FAM111B	3.01e-04	196	78	5	M7551
Coexpression	GSE34156_NOD2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_DN	NAA25 CEP85L EIF2S1 SEC31B CCDC136	3.01e-04	196	78	5	M8675
Coexpression	GSE25088_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_UP	SORT1 EPRS1 ZNF573 CEP85L FRMD4B	3.09e-04	197	78	5	M8022
Coexpression	GSE9006_HEALTHY_VS_TYPE_2_DIABETES_PBMC_AT_DX_DN	VPS13D STXBP5L RBMS1 FAS DNMBP	3.16e-04	198	78	5	M5782
Coexpression	VANTVEER_BREAST_CANCER_METASTASIS_DN	TMEM45A DLGAP5 HJURP DIAPH3	3.19e-04	109	78	4	M9826
Coexpression	GSE39556_CD8A_DC_VS_NK_CELL_MOUSE_3H_POST_POLYIC_INJ_UP	BRCA1 HMGXB4 DLGAP5 BARD1 RFC5	3.23e-04	199	78	5	M9419
Coexpression	GSE19941_UNSTIM_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_DN	ATAD5 DIAPH3 RFC5 FIGNL1 FILIP1L	3.23e-04	199	78	5	M8109
Coexpression	GSE3982_MEMORY_CD4_TCELL_VS_BCELL_UP	TAOK3 KDM5D SEC31B CLUH FRMD4B	3.23e-04	199	78	5	M5384
Coexpression	GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_DC_UP	IFT140 BRCA1 EIF2S1 SYCP1 NLRP3	3.23e-04	199	78	5	M5197
Coexpression	GSE10239_KLRG1INT_VS_KLRG1HIGH_EFF_CD8_TCELL_DN	RBMS1 HMGXB4 DLGAP5 ZNF566 CCDC136	3.23e-04	199	78	5	M3070
Coexpression	GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA5_STIM_CD8_TCELL_DN	PMS1 HJURP GTF2IRD2 PEAK1 DNMBP	3.31e-04	200	78	5	M8048
Coexpression	GSE15330_WT_VS_IKAROS_KO_GRANULOCYTE_MONOCYTE_PROGENITOR_UP	HMGXB4 ZNF566 SYCP1 RFC5 FAS	3.31e-04	200	78	5	M7027
Coexpression	GSE15750_DAY6_VS_DAY10_EFF_CD8_TCELL_UP	BRCA1 ATAD5 DIAPH3 FAS FIGNL1	3.31e-04	200	78	5	M3577
Coexpression	HALLMARK_E2F_TARGETS	BRCA1 EIF2S1 DLGAP5 BARD1 DIAPH3	3.31e-04	200	78	5	M5925
Coexpression	GSE22919_RESTING_VS_IL2_IL12_IL15_STIM_NK_CELL_DN	CNTRL DLGAP5 RFC5 DNMBP CLCC1	3.31e-04	200	78	5	M7836
Coexpression	GSE29618_PRE_VS_DAY7_FLU_VACCINE_PDC_DN	TAOK3 WASHC4 EIF2S1 RBMS1 CNTRL	3.31e-04	200	78	5	M4979
Coexpression	GSE17186_CD21LOW_VS_CD21HIGH_TRANSITIONAL_BCELL_UP	IFT140 BRCA1 FIGNL1 NLRP3 FILIP1L	3.31e-04	200	78	5	M7168
Coexpression	GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_6H_UP	VPS13D CNTRL PEAK1 FRMD4B FILIP1L	3.31e-04	200	78	5	M6096
Coexpression	GSE6674_CPG_VS_PL2_3_STIM_BCELL_DN	EPRS1 HAUS6 HMGXB4 MCTP2 UNC13A	3.31e-04	200	78	5	M6938
Coexpression	GSE9878_CTRL_VS_EBF_TRANSDUCED_PAX5_KO_PRO_BCELL_DN	EPRS1 VPS13D BRCA1 ATAD5 CYP51A1	3.31e-04	200	78	5	M6989
Coexpression	LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q	EPRS1 MIS12 CNTRL KDM5D	4.04e-04	116	78	4	M8411
Coexpression	DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2	EPRS1 EIF2S1 BARD1 RFC5	4.31e-04	118	78	4	M18086
Coexpression	HEVNER_CORTEX_APICAL_AND_BASAL_INTERMEDIATE_PROGENITOR_CELLS	AFAP1 NEUROD4 CCDC136	5.95e-04	55	78	3	MM397
CoexpressionAtlas	dev gonad_e11.5_M_PrimGermCell_Oct_k-means-cluster#2_top-relative-expression-ranked_1000	PMS1 BRCA1 DLGAP5 BARD1 DIAPH3 RFC5 FIGNL1	3.86e-05	258	76	7	gudmap_dev gonad_e11.5_M_PrimGermCell_Oct_k2_1000
CoexpressionAtlas	B cells, B.GC.Sp, CD19+ IgM+ IgD- GL7+ PNA+, Spleen, avg-3	BRCA1 ATAD5 DLGAP5 CYP51A1 BARD1 DIAPH3 FAS FIGNL1	6.38e-05	380	76	8	GSM538207_500
CoexpressionAtlas	alpha beta T cells, T.DPbl.Th, 4+ 8+ TCR-/lo FSChi, Thymus, avg-3	BRCA1 ATAD5 DLGAP5 HJURP BARD1 DIAPH3 FAS FIGNL1	8.80e-05	398	76	8	GSM399397_500
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	COL5A1 BRCA1 ATAD5 DLGAP5 HJURP BARD1 DIAPH3 FAM111B	1.40e-09	187	78	8	e41e39fd3791acf8ae5376cc5061e196d96868ae
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	COL5A1 BRCA1 ATAD5 DLGAP5 HJURP BARD1 DIAPH3 FAM111B	1.40e-09	187	78	8	cefa211ef224e803ea9467882e2ca74d0b1492f1
ToppCell	Control-Endothelial-Endothelial-FOXM1\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BRCA1 ATAD5 DLGAP5 HJURP SYCP1 BARD1 DIAPH3 FAM111B	1.52e-09	189	78	8	1e1499b062d9c647c8f38b0c4e0d871d159be5dd
ToppCell	3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	HAUS6 BRCA1 ATAD5 DLGAP5 HJURP BARD1 DIAPH3 FAM111B	1.80e-09	193	78	8	e45ce9cf8421512b57f157c24b64793b47b4ba4b
ToppCell	3'_v3-blood-Lymphocytic_NK-Cycling_NK\|blood / Manually curated celltypes from each tissue	BRCA1 ATAD5 DLGAP5 HJURP BARD1 DIAPH3 RFC5 FAM111B	1.87e-09	194	78	8	bf9734abaad603ade2a6a6940918aaf1e1c4e2cd
ToppCell	367C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	BRCA1 ATAD5 DLGAP5 HJURP BARD1 DIAPH3 RFC5 FAM111B	2.03e-09	196	78	8	9591a6a3477ed6a1e2e016f7542e38603d8b16cb
ToppCell	COVID-19_Moderate-T/NK_proliferative\|COVID-19_Moderate / disease group, cell group and cell class	BRCA1 ATAD5 DLGAP5 HJURP BARD1 DIAPH3 RFC5 FAM111B	2.20e-09	198	78	8	166c000fb0e19602ffdd8bf2b2f19be2c6df96a6
ToppCell	COVID-19_Moderate-T/NK_proliferative\|World / disease group, cell group and cell class	BRCA1 ATAD5 DLGAP5 HJURP BARD1 DIAPH3 RFC5 FAM111B	2.20e-09	198	78	8	bf0131fbca6032e1aab4aa807f8c1d3be689cb7f
ToppCell	COVID-19_Mild-T/NK_proliferative\|COVID-19_Mild / Disease condition and Cell class	BRCA1 ATAD5 DLGAP5 HJURP BARD1 DIAPH3 RFC5 FAM111B	2.29e-09	199	78	8	9f9a88d2b099646c1e1a7ee3f8d39cb1a2498ad7
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-2m-Stem_cells-Neuroepithelial_cell\|2m / Sample Type, Dataset, Time_group, and Cell type.	BRCA1 ATAD5 CNTRL DLGAP5 HJURP BARD1 DIAPH3 FAM111B	2.38e-09	200	78	8	0d9b8d51a7630e70e60c76c763ff82df4c559152
ToppCell	Control_saline-Endothelial-Endothelial-FOXM1\|Control_saline / Treatment groups by lineage, cell group, cell type	BRCA1 ATAD5 CNTRL DLGAP5 HJURP BARD1 DIAPH3 FAM111B	2.38e-09	200	78	8	9bbc7b5561151f6ff65f40b3226271def732e5d9
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-2m-Stem_cells\|2m / Sample Type, Dataset, Time_group, and Cell type.	BRCA1 ATAD5 CNTRL DLGAP5 HJURP BARD1 DIAPH3 FAM111B	2.38e-09	200	78	8	0675f580ccef705875854247bbfd4ee2bcf126a1
ToppCell	Non-neuronal-Dividing-IPC\|World / Primary Cells by Cluster	BRCA1 ATAD5 NEUROD4 DLGAP5 HJURP BARD1 DIAPH3 FAM111B	2.38e-09	200	78	8	971533181daa1bfac1f1b8c507d2013f891f9078
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	BRCA1 ATAD5 DLGAP5 HJURP BARD1 DIAPH3 RFC5 FAM111B	2.38e-09	200	78	8	af3dc76b4507bf4edd265169f5dfbbb8a19eb394
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-6m-Stem_cells-Neuroepithelial_cell\|6m / Sample Type, Dataset, Time_group, and Cell type.	BRCA1 ATAD5 DLGAP5 HJURP BARD1 DIAPH3 RFC5 FAM111B	2.38e-09	200	78	8	55501f83409e0174c756a13ad8077f5b59975e27
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-6m-Stem_cells\|6m / Sample Type, Dataset, Time_group, and Cell type.	BRCA1 ATAD5 DLGAP5 HJURP BARD1 DIAPH3 RFC5 FAM111B	2.38e-09	200	78	8	b9aad527d3ad5bc701e93fa2afdebf695b2a74bb
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	BRCA1 ATAD5 DLGAP5 HJURP BARD1 DIAPH3 FAM111B	1.97e-08	169	78	7	b253a4a50c06d36228fcd5d856c57202cbac158f
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	BRCA1 ATAD5 HJURP BARD1 DIAPH3 FIGNL1 FAM111B	1.97e-08	169	78	7	0bc8ef341ce307b19018d4ac8de0a4d04254209d
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	BRCA1 ATAD5 DLGAP5 HJURP BARD1 DIAPH3 FAM111B	2.40e-08	174	78	7	84da9faff088d05233183b425385beb054c92d1b
ToppCell	droplet-Spleen-nan-3m-Lymphocytic-immature_NKT_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BRCA1 ATAD5 DLGAP5 BARD1 DIAPH3 RFC5 FIGNL1	2.92e-08	179	78	7	54621d2b3a66e62aa76b7e444118878ed97c1e02
ToppCell	10x5'-bone_marrow-Lymphocytic_T_CD4/8-lo-Cycling_T\|bone_marrow / Manually curated celltypes from each tissue	BRCA1 ATAD5 DLGAP5 HJURP BARD1 DIAPH3 FAM111B	3.40e-08	183	78	7	a48a6313f2f144586951cece97ec31f6d72361df
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	BRCA1 ATAD5 DLGAP5 HJURP BARD1 DIAPH3 FAM111B	3.66e-08	185	78	7	30e041d6f6e310d64809e9d6d93cd30052972f3b
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	BRCA1 ATAD5 DLGAP5 HJURP BARD1 DIAPH3 FAM111B	3.94e-08	187	78	7	9351fa87b69a951af85b10bf91fe9b1cce8c0517
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	BRCA1 ATAD5 DLGAP5 HJURP BARD1 DIAPH3 FAM111B	3.94e-08	187	78	7	057569c9437219ecc396aa6e673b1178a2273837
ToppCell	droplet-Marrow-nan-3m-Hematologic-erythroblast\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL5A1 IFT140 BRCA1 ATAD5 DLGAP5 DIAPH3 FIGNL1	4.24e-08	189	78	7	8a38baee58a27c2fa3f4bd131ab9f15723ed9295
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	BRCA1 ATAD5 DLGAP5 HJURP BARD1 DIAPH3 FAM111B	4.40e-08	190	78	7	31de1727822e9818652946dfb962daee77ffad68
ToppCell	3'_v3-GI_small-bowel-Lymphocytic_T_CD4/8-lo-Cycling_T\|GI_small-bowel / Manually curated celltypes from each tissue	BRCA1 ATAD5 DLGAP5 HJURP BARD1 DIAPH3 FAM111B	4.56e-08	191	78	7	e642fa7395c05fb53324c9d46bbc52f89fc9673f
ToppCell	Mild-T/NK_proliferative\|World / Disease group and Cell class	BRCA1 ATAD5 DLGAP5 HJURP BARD1 DIAPH3 FAM111B	4.56e-08	191	78	7	9dba5526fd5ea8065ad305feb2ee562335f887c6
ToppCell	3'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	BRCA1 DLGAP5 HJURP BARD1 MCF2 DIAPH3 FAM111B	4.56e-08	191	78	7	50854384fdaa0efa2e3227659d544ed09ac102f2
ToppCell	Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like-F\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	GALNT17 C12orf56 GADL1 NXF5 SYCP1 MCTP2 ABCG5	4.89e-08	193	78	7	315840bc48899f3a36d57b19197509de19716e3d
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	BRCA1 ATAD5 DLGAP5 HJURP DIAPH3 SPAG6 FAM111B	5.07e-08	194	78	7	17af04acd54dd6a895a966cbb4422de25dc4f1e6
ToppCell	wk_20-22-Hematologic_Lymphocytic-B-Pro-B\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	BRCA1 IGHD ATAD5 DLGAP5 HJURP DIAPH3 FAM111B	5.07e-08	194	78	7	3590ff471f74a361ee5bf02a58e3104cd3bf7d00
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic-lymphocyte-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	BRCA1 ATAD5 DLGAP5 HJURP DIAPH3 SPAG6 FAM111B	5.07e-08	194	78	7	3c385d93c5fe1a7817813c492f79fdb94d887357
ToppCell	(1)_T_cells_Dividing\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	BRCA1 ATAD5 DLGAP5 HJURP BARD1 DIAPH3 FAM111B	5.07e-08	194	78	7	8f313071933451780309d2174ed27d8cdc734343
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic-lymphocyte\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	BRCA1 ATAD5 DLGAP5 HJURP DIAPH3 SPAG6 FAM111B	5.07e-08	194	78	7	635d0e88f9c542a1d9363066c6cdbc6e44db76c1
ToppCell	367C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating\|367C / Donor, Lineage, Cell class and subclass (all cells)	BRCA1 ATAD5 DLGAP5 HJURP BARD1 DIAPH3 FAM111B	5.07e-08	194	78	7	a12b64945e10f00aa983678a02586c59badc1570
ToppCell	COVID-19-T_cells-Cycling_NK/T_cells\|COVID-19 / group, cell type (main and fine annotations)	BRCA1 ATAD5 DLGAP5 HJURP BARD1 DIAPH3 FAM111B	5.25e-08	195	78	7	764ed100c28d9bc93ee5ecabc5291c8f184d78da
ToppCell	(3)_MNP-(3)_Macrophage_Dividing\|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4)	BRCA1 ATAD5 DLGAP5 HJURP BARD1 DIAPH3 FAM111B	5.63e-08	197	78	7	048bc4f8fd5d4f394e2384700640f72042336597
ToppCell	ICU-SEP-Lymphocyte-T_NK-T_NK_proliferative\|ICU-SEP / Disease, Lineage and Cell Type	BRCA1 ATAD5 DLGAP5 HJURP BARD1 DIAPH3 FAM111B	5.63e-08	197	78	7	908e91fa16134b61943aea5e8fc0d6fbac8a8c6e
ToppCell	Healthy-T/NK_proliferative\|World / disease group, cell group and cell class	BRCA1 ATAD5 DLGAP5 HJURP DIAPH3 RFC5 FAM111B	5.63e-08	197	78	7	e90be1e7e02f736b6aab14010a912b592d6f1e80
ToppCell	COVID-19_Severe-T/NK_proliferative\|COVID-19_Severe / Disease condition and Cell class	BRCA1 ATAD5 DLGAP5 HJURP DIAPH3 RFC5 FAM111B	5.63e-08	197	78	7	718a84e9a8248080f2d964e7c6a3ba183ece9592
ToppCell	wk_20-22-Hematologic_Lymphocytic-B-Large_pre-B\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	BRCA1 ATAD5 DLGAP5 HJURP DIAPH3 RFC5 FAM111B	5.63e-08	197	78	7	cebf47d66f425c84d3fea962e11f5bf4bfe2e60f
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_NK-Cycling_NK\|lymph-node_spleen / Manually curated celltypes from each tissue	BRCA1 ATAD5 DLGAP5 HJURP BARD1 DIAPH3 FAM111B	5.83e-08	198	78	7	b2868a897dd96494cf1829c30e0ce508f52efdf3
ToppCell	medial-2-Hematologic-Proliferating_Macrophage\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	BRCA1 ATAD5 DLGAP5 HJURP BARD1 DIAPH3 FAM111B	5.83e-08	198	78	7	64a2bcf5a9ba66a4fe08fbde33f1886c136cde8f
ToppCell	medial-Hematologic-Proliferating_Macrophage-2\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	BRCA1 ATAD5 DLGAP5 HJURP BARD1 DIAPH3 FAM111B	5.83e-08	198	78	7	fcc14ac3eb5088b9d6cd6af5a34dee5b81c0ece8
ToppCell	COVID-19_Severe-T/NK_proliferative\|World / disease group, cell group and cell class	BRCA1 ATAD5 DLGAP5 HJURP DIAPH3 RFC5 FAM111B	5.83e-08	198	78	7	48045689d0969ff0a14eee7086b8e19b0d6b6065
ToppCell	cycling_basal_cell\|World / shred by cell class for turbinate	BRCA1 ATAD5 DLGAP5 HJURP BARD1 DIAPH3 FAM111B	5.83e-08	198	78	7	e86c1224f5b0890a50a25257628e90c790aae7cd
ToppCell	10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Prolif_T\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	BRCA1 ATAD5 DLGAP5 HJURP BARD1 DIAPH3 FAM111B	5.83e-08	198	78	7	48d39018c56ea8ba972c72af8ece10cbeb48fbc8
ToppCell	10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Prolif_T-F_2\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	BRCA1 ATAD5 DLGAP5 HJURP BARD1 DIAPH3 FAM111B	5.83e-08	198	78	7	bcfe7b6d91f2e2f145cb2660b65fd2a6c1134b86
ToppCell	medial-Hematologic-Proliferating_Macrophage\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	BRCA1 ATAD5 DLGAP5 HJURP BARD1 DIAPH3 FAM111B	5.83e-08	198	78	7	da6963184c32761c896a9b91a5321ad84b583736
ToppCell	PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	BRCA1 ATAD5 DLGAP5 HJURP DIAPH3 RFC5 FAM111B	6.03e-08	199	78	7	11c3d9fe811a4619347f47d2b0e94066e3085625
ToppCell	mild_COVID-19-T/NK_proliferative\|World / disease group, cell group and cell class (v2)	BRCA1 ATAD5 DLGAP5 HJURP DIAPH3 RFC5 FAM111B	6.03e-08	199	78	7	d44cc74d7171d96add61dae821daf774b17d4c69
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	BRCA1 ATAD5 DLGAP5 HJURP DIAPH3 RFC5 FAM111B	6.03e-08	199	78	7	e98ff036d04fc78dffef156bdc0d644532274067
ToppCell	PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	BRCA1 ATAD5 DLGAP5 HJURP DIAPH3 RFC5 FAM111B	6.03e-08	199	78	7	36c80907b2ec1cbcd1b4e841e6c02a4792591d74
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	BRCA1 ATAD5 DLGAP5 HJURP DIAPH3 RFC5 FAM111B	6.03e-08	199	78	7	305a9ade5bbe8e981e7c641c9a5e0c9f8ef60470
ToppCell	PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	BRCA1 ATAD5 DLGAP5 HJURP DIAPH3 RFC5 FAM111B	6.03e-08	199	78	7	bf4c31902ae8358215245a2e11b5a2fe4ca1bc8c
ToppCell	COVID-19_Mild-Lymphoid_T/NK-T/NK_proliferative\|COVID-19_Mild / Disease group, lineage and cell class	BRCA1 ATAD5 DLGAP5 HJURP DIAPH3 RFC5 FAM111B	6.03e-08	199	78	7	ddea0e5c1cb6a096ab8e09a8c3c37c1bff381d9c
ToppCell	3'_v3-bone_marrow-Lymphocytic_NK-Cycling_NK\|bone_marrow / Manually curated celltypes from each tissue	BRCA1 ATAD5 DLGAP5 HJURP BARD1 DIAPH3 FAM111B	6.03e-08	199	78	7	6321140a1ebc1ff793fb6221a31e884368e42fa5
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	BRCA1 ATAD5 DLGAP5 HJURP BARD1 DIAPH3 FAM111B	6.03e-08	199	78	7	4af38f5e9d2229d64f7ecdf9c00b4d67e5f86a51
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	BRCA1 ATAD5 DLGAP5 HJURP DIAPH3 RFC5 FAM111B	6.03e-08	199	78	7	7feedb0bf84a3361c8ab5b6674ff64e8ff140c23
ToppCell	PBMC-Mild-Lymphocyte-T/NK-Other_T\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	BRCA1 ATAD5 SYNE1 DLGAP5 HJURP DIAPH3 FAM111B	6.03e-08	199	78	7	101f78fe6dd1bf9e2e4dd5ad8a970312b3540927
ToppCell	PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	BRCA1 ATAD5 DLGAP5 HJURP DIAPH3 RFC5 FAM111B	6.03e-08	199	78	7	7beb0e07a27fea94674f24eb61c381b0de38ed3e
ToppCell	COVID-19-Lymphoid-Proliferating_CD4_T_cells\|COVID-19 / Condition, Lineage and Cell class	BRCA1 ATAD5 DLGAP5 HJURP DIAPH3 RFC5 FAM111B	6.03e-08	199	78	7	e1dfc856a85a91e8f7ab8d600a8a891d16b2aefb
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	BRCA1 ATAD5 DLGAP5 HJURP DIAPH3 RFC5 FAM111B	6.03e-08	199	78	7	123fbf2122aa221d8cbf3aef9361ba0982c07695
ToppCell	B_cell_maturation-pre-B\|B_cell_maturation / Lineage and Cell class	BRCA1 ATAD5 DLGAP5 HJURP DIAPH3 RFC5 FAM111B	6.03e-08	199	78	7	4bf6a656de04d92103cbe743cd07afd9d125c654
ToppCell	PBMC-Mild-Lymphocyte-T/NK-Other_T\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	BRCA1 ATAD5 SYNE1 DLGAP5 HJURP DIAPH3 FAM111B	6.03e-08	199	78	7	e0fcec796afe75e42467ca86355b9fc5aa9ae0a1
ToppCell	367C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating\|Macrophage / Donor, Lineage, Cell class and subclass (all cells)	ATAD5 DLGAP5 HJURP BARD1 DIAPH3 RFC5 FAM111B	6.03e-08	199	78	7	88d130e2451e61afb710edf552e6b346b9fcfb2b
ToppCell	COVID-19_Severe-Lymphoid_T/NK-T/NK_proliferative\|COVID-19_Severe / Disease group, lineage and cell class	BRCA1 ATAD5 DLGAP5 HJURP DIAPH3 RFC5 FAM111B	6.03e-08	199	78	7	ddae7fe7633661f15d3c79f5187415ffbfecce67
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	BRCA1 ATAD5 DLGAP5 HJURP DIAPH3 RFC5 FAM111B	6.03e-08	199	78	7	fba48342066aab41a8bcb20db40a6df0158e1cbe
ToppCell	Influenza_Severe-T/NK_proliferative\|Influenza_Severe / Disease group and Cell class	BRCA1 ATAD5 DLGAP5 HJURP DIAPH3 RFC5 FAM111B	6.03e-08	199	78	7	2508c55f9ffe17b694c70f1283f41ad4a8e83c00
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	BRCA1 ATAD5 DLGAP5 HJURP DIAPH3 RFC5 FAM111B	6.03e-08	199	78	7	6b1304417cf9c44ca70d2bfc2b5acc1a206f25b6
ToppCell	COVID-19_Severe-T/NK_proliferative\|COVID-19_Severe / disease group, cell group and cell class	BRCA1 ATAD5 DLGAP5 HJURP DIAPH3 RFC5 FAM111B	6.03e-08	199	78	7	af78837f3a7641a5bd98765eef9cb4f86034048c
ToppCell	Dividing_Macrophages\|World / lung cells shred on cell class, cell subclass, sample id	BRCA1 ATAD5 DLGAP5 HJURP BARD1 DIAPH3 FAM111B	6.03e-08	199	78	7	5c755b6876e164dc847ef7c723f850f227cf3a87
ToppCell	LPS_IL1RA-Endothelial-Endothelial-FOXM1\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	BRCA1 ATAD5 CNTRL DLGAP5 HJURP BARD1 DIAPH3	6.03e-08	199	78	7	be2276c9a1994579ba1d2998b49bf549c1324d44
ToppCell	mild_COVID-19-T/NK_proliferative\|mild_COVID-19 / disease group, cell group and cell class (v2)	BRCA1 ATAD5 DLGAP5 HJURP DIAPH3 RFC5 FAM111B	6.03e-08	199	78	7	df2fcaf01b1b48632f84e7355ef21d20853f0664
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial-FOXM1\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	BRCA1 ATAD5 CNTRL DLGAP5 HJURP BARD1 DIAPH3	6.25e-08	200	78	7	4cfe08878a6981bf7b3567f9e82192d8f060ddde
ToppCell	distal-Hematologic-Proliferating_Macrophage\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	BRCA1 ATAD5 DLGAP5 HJURP BARD1 DIAPH3 FAM111B	6.25e-08	200	78	7	3835a8a9739b8cd5bf19c40765ef76907ac1ad38
ToppCell	COVID-19-COVID-19_Mild-Lymphocyte-T/NK-T/NK_proliferative\|COVID-19_Mild / Disease, condition lineage and cell class	BRCA1 ATAD5 DLGAP5 HJURP DIAPH3 RFC5 FAM111B	6.25e-08	200	78	7	6126a3bbafe2110fba0c1c4493035df4e8193d22
ToppCell	COVID-19-COVID-19_Severe-Lymphocyte-T/NK-T/NK_proliferative\|COVID-19_Severe / Disease, condition lineage and cell class	BRCA1 ATAD5 DLGAP5 HJURP DIAPH3 RFC5 FAM111B	6.25e-08	200	78	7	0892603e604c2a945dd720685d45970f855bd5d3
ToppCell	Biopsy_Control_(H.)-Immune-Proliferating_Macrophages\|Biopsy_Control_(H.) / Sample group, Lineage and Cell type	BRCA1 ATAD5 DLGAP5 HJURP BARD1 DIAPH3 FAM111B	6.25e-08	200	78	7	ce9fad55f779afd3d6c5a9c5a15e2d9f548b7c7e
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Proliferating-cycling_ventral_progenitors\|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type.	BRCA1 ATAD5 DLGAP5 HJURP BARD1 DIAPH3 FAM111B	6.25e-08	200	78	7	9359faa749f41aaef70b4874f20b4eed2dc12cc2
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	BRCA1 ATAD5 DLGAP5 HJURP BARD1 DIAPH3 FAM111B	6.25e-08	200	78	7	1fbed5967fc1922efe4a98f5760ad74fce210c52
ToppCell	MS-Multiple_Sclerosis-Lymphocyte-T/NK-T/NK_proliferative\|Multiple_Sclerosis / Disease, condition lineage and cell class	ATAD5 DLGAP5 HJURP BARD1 DIAPH3 RFC5 FAM111B	6.25e-08	200	78	7	7faf1e37364203a08d2b2544979e848b41e36b1c
ToppCell	distal-Hematologic-Proliferating_Macrophage-3\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	BRCA1 ATAD5 DLGAP5 HJURP BARD1 DIAPH3 FAM111B	6.25e-08	200	78	7	9c03a8da12d29618f72c429836c1d1bd84a78b12
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Proliferating\|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type.	BRCA1 ATAD5 DLGAP5 HJURP BARD1 DIAPH3 FAM111B	6.25e-08	200	78	7	cea58274efbe7f9e3c3ef9fbb768ebfb917e21d9
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	BRCA1 ATAD5 DLGAP5 HJURP DIAPH3 RFC5 FAM111B	6.25e-08	200	78	7	43571c9284d4e41402a2d1eefc1efe2ce8476d4a
ToppCell	Biopsy_Other_PF-Immune-Proliferating_Macrophages\|Biopsy_Other_PF / Sample group, Lineage and Cell type	BRCA1 ATAD5 DLGAP5 HJURP BARD1 DIAPH3 FAM111B	6.25e-08	200	78	7	61473e8613f39a92002d5b631e6bd563735566e4
ToppCell	3'-GW_trimst-2-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	BRCA1 ATAD5 DLGAP5 HJURP BARD1 DIAPH3 FAM111B	6.25e-08	200	78	7	63f9481059be608ddc9fe9c7a8f8503fce9755dd
ToppCell	BL-critical-LOC-Lymphoid-Treg\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	BRCA1 ATAD5 DLGAP5 HJURP DIAPH3 RFC5 FAM111B	6.25e-08	200	78	7	04d95a9102248e98eed069840ea6d3d23a243fd5
ToppCell	Biopsy_IPF-Immune-Proliferating_Macrophages\|Biopsy_IPF / Sample group, Lineage and Cell type	BRCA1 ATAD5 DLGAP5 HJURP BARD1 DIAPH3 FAM111B	6.25e-08	200	78	7	8abb2c25422717e994468ac02d8260344341467f
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	BRCA1 ATAD5 DLGAP5 HJURP BARD1 DIAPH3 FAM111B	6.25e-08	200	78	7	38665128b54f4a81b53c961427aed67bf4e2510b
ToppCell	Sepsis-ICU-SEP-Lymphocyte-T/NK-T/NK_proliferative\|ICU-SEP / Disease, condition lineage and cell class	BRCA1 ATAD5 DLGAP5 HJURP BARD1 DIAPH3 FAM111B	6.25e-08	200	78	7	ae500c8b7c2162cadd31bf44ee9dc3271192cf17
ToppCell	Influenza-Influenza_Severe-Lymphocyte-T/NK-T/NK_proliferative\|Influenza_Severe / Disease, condition lineage and cell class	BRCA1 ATAD5 DLGAP5 HJURP DIAPH3 RFC5 FAM111B	6.25e-08	200	78	7	e1c266525ce6b42a4451b6a3b0cabf41ff5e2ee7
ToppCell	distal-3-Hematologic-Proliferating_Macrophage\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	BRCA1 ATAD5 DLGAP5 HJURP BARD1 DIAPH3 FAM111B	6.25e-08	200	78	7	1b65c97e8123d0572d31525d6a10bc7f16857959
ToppCell	356C-Myeloid-Dendritic-cDC_proliferating_1\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	BRCA1 ATAD5 DLGAP5 HJURP DIAPH3 RFC5 FAM111B	6.25e-08	200	78	7	5b014c658eecc5e73679e5feb7a2aaa3d297001d
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Proliferating\|6_mon / Sample Type, Dataset, Time_group, and Cell type.	BRCA1 ATAD5 DLGAP5 HJURP BARD1 DIAPH3 FAM111B	6.25e-08	200	78	7	8f9e76048ae6f45218a09a95a2c4b31e8a8937b2
ToppCell	droplet-Lung-nan-3m-Lymphocytic-Proliferating_NK\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DLGAP5 BARD1 DIAPH3 RFC5 MAP10 FIGNL1	3.55e-07	158	78	6	ee8ce3cd202807df692b28bb1a81827d49d73862
ToppCell	367C-Lymphocytic-CD4_T-cell-Proliferating_T_cell\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	BRCA1 ATAD5 DLGAP5 HJURP DIAPH3 FAM111B	4.42e-07	164	78	6	fb18b863152fb3109e2224c791c84c6371680a4e
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	BRCA1 ATAD5 BARD1 DIAPH3 FIGNL1 FAM111B	4.58e-07	165	78	6	88681101d7cf60b99b8ace5d8c0944323b937306
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	BRCA1 DLGAP5 HJURP BARD1 DIAPH3 FAM111B	4.75e-07	166	78	6	2642544070564debe2deb2938d2c33997bf5ef02
Drug	2,3-bis(3'-hydroxybenzyl)butyrolactone	COL5A1 TAOK3 AFAP1 BRCA1 RBMS1 DLGAP5 HJURP BARD1 RASD1 DIAPH3 RFC5 FIGNL1 JMY FILIP1L	3.64e-06	961	77	14	ctd:C029497
Disease	Autoimmune Lymphoproliferative Syndrome Type 2B	COL5A1 FAS	1.36e-04	7	76	2	C1846545
Disease	peripheral neuropathy	GALNT17 XIRP2	1.36e-04	7	76	2	EFO_0003100
Disease	biliary atresia	AFAP1 DIAPH3 ZNF354B	4.13e-04	56	76	3	MONDO_0008867
Disease	Hereditary Breast and Ovarian Cancer Syndrome	BRCA1 BARD1	5.84e-04	14	76	2	C0677776
Disease	central nervous system disease (implicated_via_orthology)	TAOK3 SEC31B	7.67e-04	16	76	2	DOID:331 (implicated_via_orthology)
Disease	alcoholic hepatitis (biomarker_via_orthology)	FAS NLRP3	9.75e-04	18	76	2	DOID:12351 (biomarker_via_orthology)
Disease	BREAST CANCER	BRCA1 BARD1	1.33e-03	21	76	2	114480
Disease	breast cancer (implicated_via_orthology)	BRCA1 BARD1	1.89e-03	25	76	2	DOID:1612 (implicated_via_orthology)
Disease	Hereditary non-polyposis colorectal cancer syndrome	PMS1 BARD1	2.20e-03	27	76	2	C1112155
Disease	Malignant tumor of breast	BRCA1 BARD1	2.20e-03	27	76	2	cv:C0006142
Disease	Breast neoplasm	BRCA1 BARD1	2.20e-03	27	76	2	cv:C1458155
Disease	Familial cancer of breast	BRCA1 BARD1	2.20e-03	27	76	2	cv:C0346153
Disease	Hereditary Nonpolyposis Colorectal Cancer	PMS1 BARD1	2.54e-03	29	76	2	C1333990
Disease	Neoplasm of uncertain or unknown behavior of ovary	PMS1 BRCA1	2.54e-03	29	76	2	C0496920

Protein segments in the cluster

Peptide	Gene	Start	Entry
ISKDFASYCSKEKEK	UNC13A	1236	Q9UPW8
KSSDKQKDLNEKCLY	ATAD5	421	Q96QE3
YDTDCTKKFISKIKS	CCDC186	141	Q7Z3E2
SDFQCLSKKKEKLTE	CNTRL	1531	Q7Z7A1
EKVCKNYLTSKKSLP	BARD1	301	Q99728
LKKLDSQICELKYEK	CDNF	116	Q49AH0
IKDTKLLCYKSSKDQ	AFAP1	176	Q8N556
FYNCTERAEKLKDKK	DNMBP	1131	Q6XZF7
ACEEIKKSKSFSKLL	DIAPH3	826	Q9NSV4
TLYSRKSEEDKKKCE	C6orf201	16	Q7Z4U5
KEEFDKLHQKYCLKS	HJURP	581	Q8NCD3
YKKNLKLESSTHACK	PAAT	131	Q9H8K7
TKAILDKTTNKCKGY	RBMS1	91	P29558
ILDTKSCLKNKTKEN	RASD1	121	Q9Y272
SQVCATKLFKKYAEK	FIGNL1	51	Q6PIW4
ETKLKYATEKKTVDC	MAP10	591	Q9P2G4
KLGDQRYKSKTLCKS	MCTP2	381	Q6DN12
VSAKKSYLRNKKEIC	JMY	616	Q8N9B5
IKCEDKFTKSKTVYS	EIF2S1	96	P05198
KASKTFLKKNSCYTL	KDM5D	1071	Q9BY66
CKYFKDSRNIKILKD	NXF5	291	Q9H1B4
VIYCLKNKDIKSALS	OR14K1	286	Q8NGZ2
YAVKICKSKAKESQQ	PEAK1	1356	Q9H792
VRNSSKKKLKDSELY	HMGXB4	51	Q9UGU5
IDSCSSSEEIKKKKY	BRCA1	641	P38398
LCKTVKKKRKQDYTD	FRMD4B	526	Q9Y2L6
KSKQECYSLKCNLEK	FILIP1L	436	Q4L180
IKVTKTELEKLKCSY	FER	126	P16591
DKTLQKKCYLEQKTV	CYP51A1	336	Q16850
EYKCVVQHTASKSKK	IGHD	81	P01880
TKEILAQKCKTYSTK	DLGAP5	356	Q15398
KCKELKYSKDLPQIS	GALNT17	141	Q6IS24
CVDKLTKVYKDDKKL	ABCA2	991	Q9BZC7
ESAYKKSAICHKTLK	ABCG5	326	Q9H222
KEINKKRSSTLDCKY	CEP85L	216	Q5SZL2
YISSLKKKCQKESEQ	CEP85L	486	Q5SZL2
NVTLILDCKKKTTKF	COL5A1	176	P20908
LKYSKDCEGSALLKK	MCF2	646	P10911
KKSLSKKREESYLSN	HAUS6	841	Q7Z4H7
SCLEAEKKEAKQKYT	EXOC1	746	Q9NV70
VKDKSDLLKKCYSAK	GADL1	346	Q6ZQY3
LCDIKKTNESLYKSL	FAM111B	691	Q6SJ93
KLSKTKYCSQLKDSQ	GTF2IRD2	926	Q86UP8
KLSKTKYCSQLKDSQ	GTF2IRD2B	926	Q6EKJ0
ALTEAYKCLAKAKAK	IFT140	1306	Q96RY7
KQFYSTAKKCKDEIK	PMS1	156	P54277
QERTSYLEKKLSCKI	NLRP3	586	Q96P20
REVKDLKKKCTSNFL	SORT1	731	Q99523
CLLSLKAQYKEKTGK	EPRS1	856	P07814
VLTCLKDKDEYVKKN	SPAG6	256	O75602
KLKEQLTKVKECYSP	SYNE1	791	Q8NF91
KTSTILACAKQLYKD	RFC5	66	P40937
SEFKSIKKTSLIKNC	SHLD2	421	Q86V20
TTFLESQKKQYKICK	TAOK3	546	Q9H2K8
YLAKKKTKISSLLAC	SEC31B	611	Q9NQW1
KPILKVEYKTCKNSE	STXBP5L	306	Q9Y2K9
STKCFDKKLKTLEEL	SMCR8	311	Q8TEV9
KTEEYSKECLKEFKK	CCDC110	496	Q8TBZ0
SKECLKEFKKIISKY	CCDC110	501	Q8TBZ0
ELKSRLCTLQKKYDT	CCDC136	366	Q96JN2
IYSSTVLKKECKKSN	C12orf56	106	Q8IXR9
LDSLTYKIDECEKKK	CLCC1	71	Q96S66
KTKESSEYLKCLTQQ	CLUH	1186	O75153
KQYLKTKKTEASTEC	XIRP2	2571	A4UGR9
EKLYECKKCQKKFSS	ZNF573	131	Q86YE8
EKYKTELCTKQALLA	MIS12	126	Q9H081
QAKYSENKLKCTKAR	SRGAP3	226	O43295
YDTLIKDLKKANLCT	FAS	291	P25445
LKETCARSAEKTKKY	SYCP1	186	Q15431
KYITKNLLSEKNVCK	ZNF546	136	Q86UE3
KECDKAFKRLSTLTK	ZNF91	381	Q05481
YKCKECDKTFKRLST	ZNF91	686	Q05481
TIDKKFYKSLLDICK	WASHC4	331	Q2M389
SRCETKKLFLKKEIY	ZNF566	81	Q969W8
EYKEALKHCKTVLKQ	TTC37	21	Q6PGP7
TCKDEIKRYKQKSKS	WDR27	631	A2RRH5
KIKTAEKRYKCSTCE	ZNF354B	206	Q96LW1
CKKQKRTCYLGSKTL	TMEM45A	31	Q9NWC5
KKAVISYTEGLKKKC	TTC4	96	O95801
FSKTLLKTKLSEKCL	ZP2	316	Q05996
KKCKLLYESFSNQTK	VPS13D	2316	Q5THJ4
KSLLDQLKDVFSKCK	NAA25	806	Q14CX7
AIKKLDQCKDHTYKV	NEB	481	P20929
CYSKTQKLSKIETLR	NEUROD4	116	Q9HD90